Genmab | 资产

Assets 更改 日
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Almirall EUR 2.31B 67.78M 2024-03
Amarin USD 790.01M 41.67M 2024-03
Amgen USD 92.98B 4.17B 2024-03
AstraZeneca USD 102.29B 1.17B 2024-03
Bayer EUR 119.88B 3.62B 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Demant DKK 30.55B 713M 2023-12
Exelixis USD 2.8B 173.16M 2024-03
Fresenius Medical Care EUR 34.34B 1.3B 2024-03
Galapagos EUR 4.36B 3.98M 2024-03
Genmab DKK 36.68B 1.39B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
GN Store Nord DKK 29.42B 1.23B 2024-03
GRIFOLS EUR 21.44B 623.44M 2023-12
Hikma Pharmaceutical USD 4.68B 61M 2023-12
Insmed USD 1.16B 170.74M 2024-03
Lonza CHF 16.85B 824M 2023-12
Merck EUR 49.5B 1.01B 2024-03
Novartis USD 94.33B 5.61B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
UCB EUR 15.54B 157M 2023-12



Genmab 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.